Legis Daily

Advancing Enrollment and Reducing Drug Costs Act

USA119th CongressHR-2340| House 
| Updated: 3/25/2025
Chris Pappas

Chris Pappas

Democratic Representative

New Hampshire

Cosponsors (1)
Paul Tonko (Democratic)

Ways and Means Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill, titled the "Advancing Enrollment and Reducing Drug Costs Act," seeks to expand access to Medicare Part D subsidies for certain low-income individuals. It amends the Social Security Act to provide for the automatic qualification of specific Medicaid beneficiaries for premium and cost-sharing assistance under the Medicare prescription drug program. Specifically, the legislation targets Part D eligible individuals who are enrolled in a State Medicaid plan under particular provisions (Section 1902(a)(10)(A)(i)(VIII) or (ii)(XX)) on the day before they turn 65. To qualify, these individuals must also have an income below 200 percent of the federal poverty line . Such individuals will be treated as subsidy-eligible for a limited period, as determined by the Secretary, helping to reduce their out-of-pocket drug costs. The amendments made by this bill are slated to become effective for Medicare Part D plan years beginning on or after January 1, 2027 .
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-4661
Advancing Enrollment and Reducing Drug Costs Act of 2019

Bill from Previous Congress

HR 117-1167
Advancing Enrollment and Reducing Drug Costs Act of 2021

Bill from Previous Congress

HR 118-5384
Advancing Enrollment and Reducing Drug Costs Act of 2023
Mar 25, 2025
Introduced in House
Mar 25, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • Bill from Previous Congress

    HR 116-4661
    Advancing Enrollment and Reducing Drug Costs Act of 2019


  • Bill from Previous Congress

    HR 117-1167
    Advancing Enrollment and Reducing Drug Costs Act of 2021


  • Bill from Previous Congress

    HR 118-5384
    Advancing Enrollment and Reducing Drug Costs Act of 2023


  • March 25, 2025
    Introduced in House


  • March 25, 2025
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Health

Advancing Enrollment and Reducing Drug Costs Act

USA119th CongressHR-2340| House 
| Updated: 3/25/2025
This bill, titled the "Advancing Enrollment and Reducing Drug Costs Act," seeks to expand access to Medicare Part D subsidies for certain low-income individuals. It amends the Social Security Act to provide for the automatic qualification of specific Medicaid beneficiaries for premium and cost-sharing assistance under the Medicare prescription drug program. Specifically, the legislation targets Part D eligible individuals who are enrolled in a State Medicaid plan under particular provisions (Section 1902(a)(10)(A)(i)(VIII) or (ii)(XX)) on the day before they turn 65. To qualify, these individuals must also have an income below 200 percent of the federal poverty line . Such individuals will be treated as subsidy-eligible for a limited period, as determined by the Secretary, helping to reduce their out-of-pocket drug costs. The amendments made by this bill are slated to become effective for Medicare Part D plan years beginning on or after January 1, 2027 .
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

HR 116-4661
Advancing Enrollment and Reducing Drug Costs Act of 2019

Bill from Previous Congress

HR 117-1167
Advancing Enrollment and Reducing Drug Costs Act of 2021

Bill from Previous Congress

HR 118-5384
Advancing Enrollment and Reducing Drug Costs Act of 2023
Mar 25, 2025
Introduced in House
Mar 25, 2025
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  • Bill from Previous Congress

    HR 116-4661
    Advancing Enrollment and Reducing Drug Costs Act of 2019


  • Bill from Previous Congress

    HR 117-1167
    Advancing Enrollment and Reducing Drug Costs Act of 2021


  • Bill from Previous Congress

    HR 118-5384
    Advancing Enrollment and Reducing Drug Costs Act of 2023


  • March 25, 2025
    Introduced in House


  • March 25, 2025
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Chris Pappas

Chris Pappas

Democratic Representative

New Hampshire

Cosponsors (1)
Paul Tonko (Democratic)

Ways and Means Committee, Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted